2. Profile
  3. Elisabeth Poorman

Elisabeth Poorman MD MPH

Elisabeth Poorman
Designation
  • Assistant Professor of Medicine and Psychiatry
  • Assistant Program Director, Addiction Medicine Fellowship
  • Director, Addiction Consult Service at Jesse Brown VA Medical Center
Contact Information
  • epoorm2 [at] uic.edu
Website

Dr. Poorman is an addiction medicine specialist in the department of medicine and psychiatry. She is the medical director of the UIC addiction consult service as well as the Jesse Brown VA addiction consult service. Under her leadership, she directs multi-disciplinary teams to offer evidence-based, compassionate care to patients who use substances. Under her leadership, medications for substance use disorder, including methadone and buprenorphine for opioid use disorder, and naltrexone for alcohol use disorder, have increased throughout the VA hospital. Prior to her role on these consult services, she practiced as a primary care physician beginning in 2016, and completed an addiction medicine fellowship in 2021. She is also assistant program director for the addiction medicine and addiction psychiatry fellowships.

  • Utilization of Medications for Opioid Use Disorder Before and After the Implementation of an Addiction Consult Service
  • Utilization of Medications for Alcohol Use Disorder Before and After the Implementation of an Addiction Consult Service
    1. Poorman E. “The Legacy of Brazil’s Leper Colonies.” Cadernos de Saúde Coletiva. Rio de Janeiro, 16 (2): 307-326, April 2008.
    2. Poorman E, Spaulding A. “Medical Coverage of Former Inmates.” Letter to the Editor. Health Affairs. 31(8), August, 2012 
    3. Poorman E, Gazmararian J, Elon L, et al. “Is health literacy related to health behaviors and cell phone usage patterns among the text4baby population?” Archives of Public Health. 19(5): 969-989, May, 2014.
    4. Poorman E. “The Inmate Exception: A Medicaid Loophole with Serious Consequences.” SGIM Forum. 37(15): 12, December, 2014.
    5. Poorman E. “New York Addresses Needs of Mentally Ill Citizens.” SGIM Forum. 38(1), January, 2015.
    6. Poorman E, Gazmararian J, Parker RM, et al. “Use of text messaging for maternal and infant health: a systematic review of the literature.” Maternal and Child Health Journal. 19(5): 969-989, May, 2015.
    7. Torres H, Poorman E. et al. “Coverage and Access for Americans with Chronic Disease Under the Affordable Care Act: A Quasi-Experimental Study.” Annals of Internal Medicine. Philadelphia, 2017.
    8. Poorman E and Pels R. “ACGME Sends Mixed Messages on Patient Safety and Resident Wellness.” SGIM Forum. May, 2017.
    9. Poorman E. “Supporting Residents through Mental Health Crises.” SGIM Forum. April, 2017.
    10. Poorman E. “Depression and Suicide: Occupational Hazards of the Practice of Medicine.”Journal of Patient Safety and Risk Management. August 2019.
    11. Poorman E. “Number Needed to Prescribe: What would it take to get doctors to treat addiction like a disease?” Accepted to the New England Journal of Medicine, publication pending.
    12. Poorman E., Glick S. et al. “Changes in Buprenorphine and Methadone Access Among Seattle Area Persons Who Inject Drugs, 2015-2018.” Journal of Substance Abuse Treatment. March 2021.
    13. Poorman E., Messmer S., Martin M. “Outpatient Management of Alcohol Use Disorder: Best Practices.” British Medical Journal. March 4, 2023.
    14. Messmer, S., Poorman E. et al. “Outcomes of a mobile medical unit for low-threshold buprenorphine access targeting opioid overdose hot spots in Chicago” Journal of Substance Use and Addiction Treatment. July 2023.
    15. Poorman, E., McQuade, B., Messmer, S. “Medications for Alcohol Use Disorder.” American Family Physician. January 2024.